Head and Neck - Resected

A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab For Locally-Advanced Resected Head And Neck Cancer (RTOG 0920)

Please contact Jamie Ford or Caroline Holcomb at (520) 626-6800 for further information regarding our clinical trials.